Interfacing Chemical Biology and Drug Discovery
Conferences > Archives > RICT 2021

Programme

Indicated times are in CEST timezone.


Wednesday July 7, 2021
RICT Opening
09:45Opening Ceremony
Prof. Rebecca DEPREZ-POULAIN (INSERM - UNIVERSITÉ DE LILLE / INSTITUT PASTEUR OF LILLE, Lille, France)
Prof. Sebastien PAPOT (UNIVERSITY OF POITIERS, Poitiers, France)
Chemical Biology and Target validation
Session Chair
Dr Boris VAUZEILLES
(INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES, Gif-sur-Yvette, France)
10:00Expanding the Genetic Code - Chemistry in Living Systems (PL01)
Prof. Kathrin LANG
(ETH ZURICH, Zurich, Switzerland)
10:30Ligand-Directed Labeling of Endogenous Proteins in Live Cells (PL02)
Prof. Itaru HAMACHI
(KYOTO UNIVERSITY, Kyoto, Japan)
11:00Networking & Exhibition break
Session Chair
Dr Frédéric SCHMIDT
(INSTITUT CURIE, Paris, France)
11:30Bioorthogonal Protein Activation in Living Systems (PL03)
Prof. Peng CHEN
(PEKING UNIVERSITY, Beijing, China)
12:00Chemical Biology Tools for Enlightening Therapies (IL01)
Prof. Olalla VÁZQUEZ
(PHILIPPS-UNIVERSITÄT MARBURG, Marburg, Germany)
12:20End of morning session
Poster Session 1
Exhibition
Networking
New Modalities in Drug Discovery
Session Chair
Prof. Mélanie ETHEVE-QUELQUEJEU
(UNIVERSITÉ DE PARIS, Paris, France)
15:00Chemical Targeting of DNA and Histone Methylationto Reprogram Cells in Human Diseases: Challenges and Future Perspectives (PL04)
Dr Paola B. ARIMONDO
(INSTITUT PASTEUR - CNRS, Paris, France)
15:30The Second Dimension of the Genetic Code (PL05)
Prof. Thomas CARELL
(LUDWIG-MAXIMILIANS-UNIVERSITY, München, Germany)
16:00Networking & Exhibition break
Session Chair
Dr Maria DUCA
(UNIVERSITY OF CÔTE D'AZUR, Nice, France)
16:30From Simple to Complex in Natural Product Chemistry: Bio-Inspired Strategies to Escape “Flatland” (PL06)
Prof. Erwan POUPON
(PARIS-SACLAY UNIVERSITY, Châtenay-Malabry, France)
17:00Taming Random Conjugation: a General Approach for Equimolar Linking of Proteins and Payloads (IL02)
Dr Sergii KOLODYCH
(SYNDIVIA, Strasbourg, France)
17:20End of afternoon session
Thursday July 8, 2021
Case Studies and Disclosures
Session Chair
Dr Pascal GEORGE
(SCIENTIFIC EXPERT & ADVISER IN DRUG DESIGN AND DEVELOPMENT, Longvilliers, France)
10:00Steroid Sulfatase Inhibition: from Concept to Clinical and Beyond (PL07)
Prof. Barry POTTER
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)
10:30Recent Advances In Breast Cancer Treatment: Discovery of Amcenestrant (SAR439859), An Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) to Treat ER+ Breast Cancers (PL08)
Dr Youssef EL AHMAD
(SANOFI, Vitry Sur Seine, France)
11:00Networking & Exhibition break
Session Chair
Dr Olivier MIRGUET
(EVOTEC, Celle-L’Evescault, France)
11:30Daridorexant - a Dual Orexin Receptor Antagonist (PL09)
Dr Christoph BOSS
(IDORSIA PHARMACEUTICALS LTD, Basel, Switzerland)
12:00Anti-Virulence Agent to Treat S. Aureus Infections (IL03)
Dr Alessia MICHELOTTI
(BIOVERSYS AG, Lille, France)
12:20End of morning session
Poster Session 2
Exhibition
Networking
New Tools for Therapeutic Innovation
Session Chair
Prof. Sébastien LECOMMANDOUX
(LCPO, ENSCBP-BORDEAUX INP, Pessac, France)
15:00Multi-Target-Directed Ligands to Combat Neurodegenerative Diseases: All-In-One and One-For-All (PL10)
Prof. Maria Laura BOLOGNESI
(UNIVERSITY OF BOLOGNA, Bologna, Italy)
15:30Converting Drug Delivery Technologies into Drugs in Unmet Medical Needs (PL11)
Prof. Jean-Christophe LEROUX
(ETH ZÜRICH, Zürich, Switzerland)
16:00Networking & Exhibition break
Prize Ceremony - Paul Ehrlich Prize
16:30Paul Ehrlich Prize Ceremony
Dr Susana CONDE CEIDE (JANSSEN, Toledo, Spain)
Dr Dominique LESUISSE (SCT & SANOFI, Chilly-Mazarin, France)
16:40Paul Ehrlich Award Lecture - 30 Years of Molecular Glues: Controlling Cell Circuitry in Biology and Medicine (PL12)
Prof. Stuart SCHREIBER
(HARVARD UNIVERSITY, Cambridge, United States)
17:25End of afternoon session
Friday July 9, 2021
Drugging the Undruggable
Session Chair
Dr Gilles GUICHARD
(UNIVERSITY OF BORDEAUX, CBMN, Bordeaux, France)
10:00Targeting Protein-Protein Interactions in Receptor Complexes (PL13)
Prof. Kristian STROMGAARD
(UNIVERSITY OF COPENHAGEN, Copenhagen, Denmark)
10:30Selecting Targets to Harness the Therapeutic Opportunities Afforded by PROTAC-mediated Protein Degradation (PL14)
Dr John HARLING
(GLAXOSMITHKLINE, Stevenage, United Kingdom)
11:00Networking & Exhibition break
Session Chair
Prof. Dominique BONNET
(CNRS-UNIVERSITY OF STRASBOURG, Illkirch, France)
11:30Proteomimetics as Inhibitors of Transcription Factor Complexes (PL15)
Prof. Tom GROSSMANN
(VU UNIVERSITY AMSTERDAM, Amsterdam, The Netherlands)
12:00Drugging KRAS with Medchem 2.0 (PL16)
Dr Darryl MCCONNELL
(BOEHRINGER INGELHEIM, Austria)
12:30End of morning session
Poster Session 3
Exhibition
Networking
Success Stories
Session Chair
Prof. Philippe BARTHELEMY
(UNIVERSITY OF BORDEAUX, Bordeaux, France)
15:00Identification of the Potent, Highly Selective and Orally Bioavailable ATR Inhibitor BAY 1895344 (PL17)
Dr Franz VON NUSSBAUM
(NUVISAN, Berlin, Germany)
15:30Biomimetic Chemistry of Human RNAi Therapeutics (PL18)
Dr Muthiah MANOHARAN
(ALNYLAM PHARMACEUTICALS, Cambridge, United States)
16:00Networking & Exhibition break
Prize Ceremony - Pierre Fabre Award Lecture
16:30Pierre Fabre Award Ceremony
Prof. Sebastien PAPOT
(UNIVERSITY OF POITIERS, Poitiers, France)
16:40Pierre Fabre Award Lecture - Metal Complexes in Medicinal Chemistry (PL19)
Dr Gilles GASSER
(CHIMIE PARISTECH, PSL UNIVERSITY, Paris, France)
17:25Closing Remarks
Prof. Rebecca DEPREZ-POULAIN
(INSERM - UNIVERSITÉ DE LILLE / INSTITUT PASTEUR OF LILLE, Lille, France)
17:30End of RICT 2021

Copyright 2024 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys